$EFSI
EAGLE FINANCIAL SERVICES INC Stock $efsi

$efsi Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000095017024038718 Filed on March 29, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$21.91M	$22.02M	$0.00
YoY Change	18.07%	36.2%	-100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$248.0K	$632.0K	$1.990M
YoY Change	1.64%	-2.92%	103.27%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$9.488M		$32.84M
YoY Change	60.43%		499.98%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$3.043M	$2.296M	$10.63M
YoY Change	-2.47%	-40.63%	-39.83%
Income Tax	$495.0K	-$99.00K	$1.276M
% Of Pretax Income	16.27%	-4.31%	12.0%
Net Earnings	$2.548M	$2.395M	$9.357M
YoY Change	-1.43%	-25.09%	-35.56%
Net Earnings / Revenue	11.63%	10.88%
Basic Earnings Per Share	$0.72	$0.69	$2.66
Diluted Earnings Per Share	$0.72	$0.68	$2.66
COMMON SHARES
Basic Shares Outstanding	3.557M	3.521M	3.524M
Diluted Shares Outstanding	3.557M		3.524M

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$127.6M	$138.4M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$17.95M	$18.11M	$18.11M
YoY Change	0.71%	0.24%	0.24%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$1.783B	$1.826B	$1.826B
YoY Change	1.49%	12.92%	12.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$4.588M	$4.653M	$4.653M
YoY Change	-6.33%	-6.53%	-6.53%
Deferred Revenue
YoY Change
Short-Term Debt	$347.0K	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.935M	$4.653M	$4.653M
YoY Change	0.76%	-6.53%	-6.53%
LONG-TERM LIABILITIES
Long-Term Debt	$29.46M	$29.44M	$29.44M
YoY Change	0.23%	0.23%	0.23%
Other Long-Term Liabilities	$11.86M	$16.45M	$16.45M
YoY Change	47.87%	21.36%	21.36%
Total Long-Term Liabilities	$41.32M	$45.90M	$45.90M
YoY Change	10.44%	6.9%	6.9%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.935M	$4.653M	$4.653M
Total Long-Term Liabilities	$41.32M	$45.90M	$45.90M
Total Liabilities	$1.675B	$1.717B	$1.717B
YoY Change	1.39%	13.35%	13.35%
SHAREHOLDERS EQUITY
Retained Earnings	$104.4M	$103.4M
YoY Change	4.61%	3.16%
Common Stock	$8.705M	$8.660M
YoY Change	0.62%	0.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$107.7M	$108.4M	$108.4M
YoY Change
Total Liabilities & Shareholders Equity	$1.783B	$1.826B	$1.826B
YoY Change	1.49%	12.92%	12.92%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$2.548M	$2.395M	$9.357M
YoY Change	-1.43%	-25.09%	-35.56%
Depreciation, Depletion And Amortization	$248.0K	$632.0K	$1.990M
YoY Change	1.64%	-2.92%	103.27%
Cash From Operating Activities	$6.754M	-$6.012M	$6.875M
YoY Change	3056.07%	-165.43%	-50.23%
INVESTING ACTIVITIES
Capital Expenditures	$94.00K	-$56.00K	$1.071M
YoY Change	1242.86%	-116.23%	27.8%
Acquisitions
YoY Change
Other Investing Activities	$25.89M	-$24.61M	-$129.2M
YoY Change	-134.47%	-79.45%	-60.9%
Cash From Investing Activities	$25.80M	-$24.56M	-$130.3M
YoY Change	-134.35%	-79.56%	-60.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-43.27M	26.89M	194.9M
YoY Change	-131.65%	-81.05%	-39.17%
NET CHANGE
Cash From Operating Activities	6.754M	-6.012M	6.875M
Cash From Investing Activities	25.80M	-24.56M	-130.3M
Cash From Financing Activities	-43.27M	26.89M	194.9M
Net Change In Cash	-10.72M	-3.685M	71.46M
YoY Change	-117.34%	-111.9%	2428.63%
FREE CASH FLOW
Cash From Operating Activities	$6.754M	-$6.012M	$6.875M
Capital Expenditures	$94.00K	-$56.00K	$1.071M
Free Cash Flow	$6.660M	-$5.956M	$5.804M
YoY Change	3117.39%	-167.35%	-55.27%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	efsi	Not Found During Migration Deprecated Concept No Trading Symbol Flag NotFoundDuringMigrationDeprecatedConceptNoTradingSymbolFlag	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000880641
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	efsi	Nonaccrual With An Allowance For Credit Losses NonaccrualWithAnAllowanceForCreditLosses
CY2023Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilities
CY2022Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilities
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssets
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssets
CY2023	efsi	Number Of Preceding Years Undistributed Net Income NumberOfPrecedingYearsUndistributedNetIncome	P3Y
CY2023Q4	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherAssets
CY2023Q4	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherLiabilities
CY2022Q4	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherAssets
CY2022Q4	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherLiabilities
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	0-20146
CY2023	dei	Entity Registrant Name EntityRegistrantName	EAGLE FINANCIAL SERVICES, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	VA
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	54-1601306
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	2 East Main Street
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	P.O. Box 391
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Berryville
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	VA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	22611
CY2023	dei	City Area Code CityAreaCode	(540)
CY2023	dei	Local Phone Number LocalPhoneNumber	955-2510
CY2023	dei	Security12g Title Security12gTitle	Common Stock, Par Value $2.50
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	94161812
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3557229
CY2023	dei	Auditor Name AuditorName	Yount, Hyde & Barbour, P.C.
CY2023	dei	Auditor Location AuditorLocation	Winchester, Virginia
CY2023Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	15417000
CY2022Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	16629000
CY2023Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	96649000
CY2022Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	49902000
CY2023Q4	us-gaap	Federal Funds Sold FederalFundsSold	26287000
CY2022Q4	us-gaap	Federal Funds Sold FederalFundsSold	363000
CY2023Q4	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	138353000
CY2022Q4	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	66894000
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	137443000
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	149156000
CY2023Q4	us-gaap	Restricted Investments RestrictedInvestments	9568000
CY2022Q4	us-gaap	Restricted Investments RestrictedInvestments	9233000
CY2023Q4	us-gaap	Loans Receivable Held For Sale Amount LoansReceivableHeldForSaleAmount	1661000
CY2022Q4	us-gaap	Loans Receivable Held For Sale Amount LoansReceivableHeldForSaleAmount	153000
CY2023Q4	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	1462686000
CY2022Q4	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	1323783000
CY2023Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	14493000
CY2022Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	11218000
CY2023Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1448193000
CY2022Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1312565000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	18108000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	18064000
CY2023Q4	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	0
CY2022Q4	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	108000
CY2023Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	29575000
CY2022Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	23862000
CY2023Q4	us-gaap	Other Assets OtherAssets	42696000
CY2022Q4	us-gaap	Other Assets OtherAssets	36682000
CY2023Q4	us-gaap	Assets Assets	1825597000
CY2022Q4	us-gaap	Assets Assets	1616717000
CY2023Q4	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	436619000
CY2022Q4	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	478750000
CY2023Q4	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	656439000
CY2022Q4	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	627431000
CY2023Q4	us-gaap	Time Deposits TimeDeposits	413264000
CY2022Q4	us-gaap	Time Deposits TimeDeposits	157894000
CY2023Q4	us-gaap	Deposits Domestic DepositsDomestic	1506322000
CY2022Q4	us-gaap	Deposits Domestic DepositsDomestic	1264075000
CY2023Q4	us-gaap	Federal Funds Purchased FederalFundsPurchased	0
CY2022Q4	us-gaap	Federal Funds Purchased FederalFundsPurchased	32980000
CY2023Q4	us-gaap	Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch	20000000
CY2022Q4	us-gaap	Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch	175000000
CY2023Q4	us-gaap	Federal Home Loan Bank Advances Long Term FederalHomeLoanBankAdvancesLongTerm	145000000
CY2022Q4	us-gaap	Federal Home Loan Bank Advances Long Term FederalHomeLoanBankAdvancesLongTerm	0
CY2023Q4	us-gaap	Subordinated Debt SubordinatedDebt	29444000
CY2022Q4	us-gaap	Subordinated Debt SubordinatedDebt	29377000
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	16452000
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	13556000
CY2023Q4	us-gaap	Liabilities Liabilities	1717218000
CY2022Q4	us-gaap	Liabilities Liabilities	1514988000
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	10
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	10
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	2.5
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	2.5
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000
CY2023	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	48642000
CY2022	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	47383000
CY2023	efsi	Noninterest Income Fiduciary Activities NoninterestIncomeFiduciaryActivities	4926000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3520894
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3520894
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	56914
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3490086
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3490086
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	38780
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	8660000
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	8629000
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	14280000
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13268000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	103445000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	100278000
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-18006000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-20446000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	108379000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	101729000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1825597000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1616717000
CY2023	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	75520000
CY2022	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	50682000
CY2023	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	3141000
CY2022	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	3292000
CY2023	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	16000
CY2022	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	221000
CY2023	us-gaap	Dividend Income Operating DividendIncomeOperating	523000
CY2022	us-gaap	Dividend Income Operating DividendIncomeOperating	109000
CY2023	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	3768000
CY2022	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	352000
CY2023	us-gaap	Interest Income Federal Funds Sold InterestIncomeFederalFundsSold	160000
CY2022	us-gaap	Interest Income Federal Funds Sold InterestIncomeFederalFundsSold	30000
CY2023	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	83128000
CY2022	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	54686000
CY2023	us-gaap	Interest Expense Deposits InterestExpenseDeposits	23630000
CY2022	us-gaap	Interest Expense Deposits InterestExpenseDeposits	2941000
CY2023	us-gaap	Interest Expense Federal Funds Purchased InterestExpenseFederalFundsPurchased	70000
CY2022	us-gaap	Interest Expense Federal Funds Purchased InterestExpenseFederalFundsPurchased	170000
CY2023	us-gaap	Interest Expense Loans From Other Federal Home Loan Banks InterestExpenseLoansFromOtherFederalHomeLoanBanks	7720000
CY2022	us-gaap	Interest Expense Loans From Other Federal Home Loan Banks InterestExpenseLoansFromOtherFederalHomeLoanBanks	1295000
CY2023	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	1417000
CY2022	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	1067000
CY2023	us-gaap	Interest Expense InterestExpense	32837000
CY2022	us-gaap	Interest Expense InterestExpense	5473000
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	50291000
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	49213000
CY2023	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	1649000
CY2022	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	1830000
CY2022	efsi	Noninterest Income Fiduciary Activities NoninterestIncomeFiduciaryActivities	4149000
CY2023	efsi	Noninterest Income Service Chargeson Deposit Accounts NoninterestIncomeServiceChargesonDepositAccounts	1810000
CY2022	efsi	Noninterest Income Service Chargeson Deposit Accounts NoninterestIncomeServiceChargesonDepositAccounts	1618000
CY2023	efsi	Noninterest Income Other Service Chargesand Fees NoninterestIncomeOtherServiceChargesandFees	4413000
CY2022	efsi	Noninterest Income Other Service Chargesand Fees NoninterestIncomeOtherServiceChargesandFees	3943000
CY2023	efsi	Gain On Sale Of Marine Finance Assets GainOnSaleOfMarineFinanceAssets	435000
CY2022	efsi	Gain On Sale Of Marine Finance Assets GainOnSaleOfMarineFinanceAssets	0
CY2023	efsi	Gain Loss On Sale Of Bank Premises And Equipment GainLossOnSaleOfBankPremisesAndEquipment	14000
CY2022	efsi	Gain Loss On Sale Of Bank Premises And Equipment GainLossOnSaleOfBankPremisesAndEquipment	-11000
CY2023	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	0
CY2022	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	-737000
CY2023	efsi	Gain On Sale Of Loans Held For Sale GainOnSaleOfLoansHeldForSale	1428000
CY2022	efsi	Gain On Sale Of Loans Held For Sale GainOnSaleOfLoansHeldForSale	1875000
CY2023	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	713000
CY2022	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	626000
CY2023	us-gaap	Noninterest Income Other NoninterestIncomeOther	1006000
CY2022	us-gaap	Noninterest Income Other NoninterestIncomeOther	1882000
CY2023	us-gaap	Noninterest Income NoninterestIncome	14745000
CY2022	us-gaap	Noninterest Income NoninterestIncome	13345000
CY2023	us-gaap	Labor And Related Expense LaborAndRelatedExpense	30306000
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	25730000
CY2023	us-gaap	Occupancy Net OccupancyNet	2202000
CY2022	us-gaap	Occupancy Net OccupancyNet	2068000
CY2023	us-gaap	Equipment Expense EquipmentExpense	1299000
CY2022	us-gaap	Equipment Expense EquipmentExpense	1121000
CY2023	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1157000
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	770000
CY2023	us-gaap	Supplies And Postage Expense SuppliesAndPostageExpense	191000
CY2022	us-gaap	Supplies And Postage Expense SuppliesAndPostageExpense	199000
CY2023	efsi	Atm Network Fees AtmNetworkFees	1563000
CY2022	efsi	Atm Network Fees AtmNetworkFees	1313000
CY2023	efsi	Other Real Estate Owned Expense OtherRealEstateOwnedExpense	5000
CY2022	efsi	Other Real Estate Owned Expense OtherRealEstateOwnedExpense	34000
CY2023	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	7000
CY2022	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	0
CY2023	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	1585000
CY2022	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	614000
CY2023	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	1360000
CY2022	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	960000
CY2023	efsi	Bank Franchise Tax BankFranchiseTax	1255000
CY2022	efsi	Bank Franchise Tax BankFranchiseTax	886000
CY2023	us-gaap	Professional Fees ProfessionalFees	2540000
CY2022	us-gaap	Professional Fees ProfessionalFees	2019000
CY2023	efsi	Dataprocessingfees Dataprocessingfees	1935000
CY2022	efsi	Dataprocessingfees Dataprocessingfees	1779000
CY2023	us-gaap	Other Noninterest Expense OtherNoninterestExpense	7363000
CY2022	us-gaap	Other Noninterest Expense OtherNoninterestExpense	5564000
CY2023	us-gaap	Noninterest Expense NoninterestExpense	52754000
CY2022	us-gaap	Noninterest Expense NoninterestExpense	43057000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	10633000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	17671000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1276000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3150000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	9357000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	14521000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.66
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.17
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.66
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.17
CY2023	us-gaap	Net Income Loss NetIncomeLoss	9357000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	14521000
CY2023	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	-3000
CY2022	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	0
CY2023	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	5000
CY2022	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	0
CY2023	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	650000
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-5394000
CY2023	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	2445000
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-20291000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2440000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-20291000
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	11797000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5770000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	110280000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	14521000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-20291000
CY2022	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	23079
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1017000
CY2022	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	5582
CY2022	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	199000
CY2022	us-gaap	Stock Issued During Period Shares Employee Benefit Plan StockIssuedDuringPeriodSharesEmployeeBenefitPlan	4697
CY2022	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	164000
CY2022	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	4442
CY2022	efsi	Changes In Shareholder Equity Retirement Of Common Stock ChangesInShareholderEquityRetirementOfCommonStock	-154000
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.15
CY2022	us-gaap	Dividends Common Stock DividendsCommonStock	4007000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	101729000
CY2023	us-gaap	Allowance For Loan And Lease Losses Adjustments Net AllowanceForLoanAndLeaseLossesAdjustmentsNet	-1961000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	9357000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2440000
CY2023	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	17402
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1213000
CY2023	us-gaap	Stock Issued During Period Shares Employee Benefit Plan StockIssuedDuringPeriodSharesEmployeeBenefitPlan	3803
CY2023	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	132000
CY2023	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	8531
CY2023	efsi	Changes In Shareholder Equity Retirement Of Common Stock ChangesInShareholderEquityRetirementOfCommonStock	-302000
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.2
CY2023	us-gaap	Dividends Common Stock DividendsCommonStock	4229000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	108379000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	9357000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	14521000
CY2023	us-gaap	Depreciation Depreciation	1002000
CY2022	us-gaap	Depreciation Depreciation	979000
CY2023	efsi	Amortization Of Intangible And Other Assets AmortizationOfIntangibleAndOtherAssets	988000
CY2022	efsi	Amortization Of Intangible And Other Assets AmortizationOfIntangibleAndOtherAssets	931000
CY2023	us-gaap	Payments For Origination And Purchases Of Loans Held For Sale PaymentsForOriginationAndPurchasesOfLoansHeldForSale	41606000
CY2022	us-gaap	Payments For Origination And Purchases Of Loans Held For Sale PaymentsForOriginationAndPurchasesOfLoansHeldForSale	14276000
CY2023	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	41224000
CY2022	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	15486000
CY2023	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	1428000
CY2022	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	1875000
CY2023	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	1649000
CY2022	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	1830000
CY2023	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	7000
CY2022	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	0
CY2023	efsi	Gain On Sale Of Marine Finance Assets GainOnSaleOfMarineFinanceAssets	435000
CY2022	efsi	Gain On Sale Of Marine Finance Assets GainOnSaleOfMarineFinanceAssets	0
CY2023	efsi	Gain Loss On The Sale Of Bank Premises And Equipment GainLossOnTheSaleOfBankPremisesAndEquipment	-14000
CY2022	efsi	Gain Loss On The Sale Of Bank Premises And Equipment GainLossOnTheSaleOfBankPremisesAndEquipment	11000
CY2023	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	0
CY2022	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	-737000
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	67000
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	51000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1213000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1017000
CY2023	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-335000
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-562000
CY2023	efsi	Bank Owned Life Insurance Income Expense Net BankOwnedLifeInsuranceIncomeExpenseNet	713000
CY2022	efsi	Bank Owned Life Insurance Income Expense Net BankOwnedLifeInsuranceIncomeExpenseNet	626000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1509000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-86000
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	4583000
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	4742000
CY2023	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	1335000
CY2022	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	-706000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6875000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	13814000
CY2023	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	14473000
CY2022	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	27630000
CY2023	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0
CY2022	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	15370000
CY2023	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0
CY2022	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	26819000
CY2023	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	4975000
CY2022	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	0
CY2023	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	5310000
CY2022	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	8184000
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	39000
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	33000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1071000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	838000
CY2023	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	5000000
CY2022	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	0
CY2023	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	115000
CY2022	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	0
CY2023	us-gaap	Debt Instrument Increase Decrease Other Net DebtInstrumentIncreaseDecreaseOtherNet	0
CY2022	us-gaap	Debt Instrument Increase Decrease Other Net DebtInstrumentIncreaseDecreaseOtherNet	700000
CY2023	us-gaap	Proceeds From Sale Of Finance Receivables ProceedsFromSaleOfFinanceReceivables	53987000
CY2022	us-gaap	Proceeds From Sale Of Finance Receivables ProceedsFromSaleOfFinanceReceivables	0
CY2023	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	-51871000
CY2022	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	-155525000
CY2023	efsi	Proceeds From Origination Of Loans Net Of Principal Collected ProceedsFromOriginationOfLoansNetOfPrincipalCollected	-243441000
CY2022	efsi	Proceeds From Origination Of Loans Net Of Principal Collected ProceedsFromOriginationOfLoansNetOfPrincipalCollected	-492592000
CY2023	efsi	Funding Of Capital Commitments Related To Other Investments FundingOfCapitalCommitmentsRelatedToOtherInvestments	-922000
CY2022	efsi	Funding Of Capital Commitments Related To Other Investments FundingOfCapitalCommitmentsRelatedToOtherInvestments	-761000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-130284000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-331336000
CY2023	us-gaap	Increase Decrease In Other Deposits IncreaseDecreaseInOtherDeposits	-13123000
CY2022	us-gaap	Increase Decrease In Other Deposits IncreaseDecreaseInOtherDeposits	52530000
CY2023	us-gaap	Increase Decrease In Time Deposits IncreaseDecreaseInTimeDeposits	255370000
CY2022	us-gaap	Increase Decrease In Time Deposits IncreaseDecreaseInTimeDeposits	34310000
CY2023	us-gaap	Interest Expense Federal Funds Purchased Increase Decrease InterestExpenseFederalFundsPurchasedIncreaseDecrease	-32980000
CY2022	us-gaap	Interest Expense Federal Funds Purchased Increase Decrease InterestExpenseFederalFundsPurchasedIncreaseDecrease	32980000
CY2023	us-gaap	Increase Decrease In Federal Funds Purchased And Securities Sold Under Agreements To Repurchase Net IncreaseDecreaseInFederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchaseNet	-155000000
CY2022	us-gaap	Increase Decrease In Federal Funds Purchased And Securities Sold Under Agreements To Repurchase Net IncreaseDecreaseInFederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchaseNet	175000000
CY2023	efsi	Advances Of Long Term Federal Home Loan Bank Advances AdvancesOfLongTermFederalHomeLoanBankAdvances	145000000
CY2022	efsi	Advances Of Long Term Federal Home Loan Bank Advances AdvancesOfLongTermFederalHomeLoanBankAdvances	0
CY2023	us-gaap	Proceeds From Issuance Of Subordinated Long Term Debt ProceedsFromIssuanceOfSubordinatedLongTermDebt	0
CY2022	us-gaap	Proceeds From Issuance Of Subordinated Long Term Debt ProceedsFromIssuanceOfSubordinatedLongTermDebt	29326000
CY2023	efsi	Issuance Of Common Stock Employee Benefit Plan IssuanceOfCommonStockEmployeeBenefitPlan	132000
CY2022	efsi	Issuance Of Common Stock Employee Benefit Plan IssuanceOfCommonStockEmployeeBenefitPlan	164000
CY2023	efsi	Paymentsfor Retirement Of Common Stock PaymentsforRetirementOfCommonStock	302000
CY2022	efsi	Paymentsfor Retirement Of Common Stock PaymentsforRetirementOfCommonStock	154000
CY2023	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	4229000
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	3808000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	194868000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	320348000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	71459000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2826000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	66894000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	64068000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	138353000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	66894000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	31332000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	4563000
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	2068000
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	4368000
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-3095000
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-25685000
CY2023	efsi	Minimum Postretirement Liability Adjustment MinimumPostretirementLiabilityAdjustment	-8000
CY2022	efsi	Minimum Postretirement Liability Adjustment MinimumPostretirementLiabilityAdjustment	0
CY2023	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	304000
CY2022	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	108000
CY2023	us-gaap	Stock Issued1 StockIssued1	0
CY2022	us-gaap	Stock Issued1 StockIssued1	199000
CY2023Q4	efsi	Consolidated Financial Ownership Wholly Owned Subsidiary Percentage ConsolidatedFinancialOwnershipWhollyOwnedSubsidiaryPercentage	1
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-size:10pt;margin-top:14pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span></p><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The material estimate that is particularly susceptible to significant change in the near term relates to the determination of the allowance for credit losses on loans.</span></p>
CY2023	efsi	Sale Of Non Mortgage Loans SaleOfNonMortgageLoans	59600000
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	4600000
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	3500000
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-size:10pt;margin-top:14pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Risks by Loan Portfolio Segment</span></p><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">One-to-Four-Family Residential Real Estate Lending</span></p><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Residential mortgage loans generally are made on the basis of the borrower’s ability to make repayment from employment and other income and are secured by real estate whose value tends to be readily ascertainable. As part of the application process, information is gathered concerning income, employment and credit history of the applicant. The valuation of residential collateral is provided by independent fee appraisers who have been approved by the Bank’s Directors Loan Committee.</span></p><p style="font-size:10pt;margin-top:14pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Commercial Real Estate Lending</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Commercial real estate lending entails significant additional risk as compared with residential mortgage lending. Commercial real estate loans typically involve larger loan balances concentrated with single borrowers or groups of related borrowers. Additionally, the repayment of loans secured by income producing properties is typically dependent on the successful operation of a business or a real estate project and thus may be subject, to a greater extent, to adverse conditions in the real estate market or the economy, in general.</span></p><p style="font-size:10pt;margin-top:14pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Construction and Land Development Lending</span></p><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">There are two characteristics of construction lending which impact its overall risk as compared to residential mortgage lending. First, there is more concentration risk due to the extension of a large loan balance through several lines of credit to a single developer or contractor. Second, there is more collateral risk due to the fact that loan funds are provided to the borrower based upon the estimated value of the collateral after completion. This could cause an inaccurate estimate of the amount needed to complete construction or an excessive loan-to-value ratio. To mitigate the risks associated with construction lending, the Bank generally limits loan amounts to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">80</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the estimated appraised value of the finished home or other real estate property.</span></p><p style="font-size:10pt;margin-top:14pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Commercial and Industrial Lending</span></p><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Commercial business loans generally have more risk than residential mortgage loans, but have higher yields. To manage these risks, the Bank generally obtains appropriate collateral and personal guarantees from the borrower’s principal owners and monitors the financial condition of the borrower. Commercial business loans typically are made on the basis of the borrower’s ability to make repayment from cash flow from its business and are secured by business assets, such as accounts receivable, equipment, inventory and boats. As a result, the availability of funds for the repayment of commercial business loans is substantially dependent on the success of the business itself. Furthermore, the collateral for commercial business loans may depreciate over time and generally cannot be appraised with as much precision as residential real estate.</span></p><p style="font-size:10pt;margin-top:14pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Consumer Lending</span></p><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Consumer loans generally entail greater risk than residential mortgage loans, particularly in the case of consumer loans which are unsecured or secured by rapidly depreciable assets such as automobiles. A portion of the Company’s consumer loans are also secured by boats. In such cases, any repossessed collateral on a defaulted consumer loan may not provide an adequate source of repayment of the outstanding loan balance as a result of the greater likelihood of damage, loss or depreciation.</span></p><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Marine Lending</span></p><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Bank’s marine loan portfolio is comprised of originated retail loans. Through August 22, 2023, the marine loan portfolio also included dealer floor plan loans, classified as commercial and industrial loans. On August 23, 2023, the Company completed the sale of certain assets of its marine finance division to an unrelated third-party. Under the sales agreements, the Company sold its interest in marine floor plan loans, while retaining ownership of its marine retail loans which continue to constitute a significant portion of the Company's assets, revenues, and earnings. The Company expects to cease accepting new marine lending business and hold the retained outstanding loans until they are ultimately repaid.</span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company’s relationships were limited to well established dealers of global premium brand manufacturers, with the top three manufacturer customers have been in business between 30 and 100 years. Retail loans were generally limited to premium manufactures with established relationships with the Company, which have a vested interest in the secondary market pricing of their respective brand due to the limited inventory available for resale. Consequently, while not contractually committed, manufacturers will often support secondary resale values which can have the effect of reducing losses from non-performing retail marine loans. Retail borrowers generally have very high credit scores, substantial down payments, substantial net worth, personal liquidity, and excess cash flow.</span></p>
CY2023Q4	efsi	Percentage Limit Of Estimated Appraised Value Of Home PercentageLimitOfEstimatedAppraisedValueOfHome	0.80
CY2023Q4	efsi	Reserve Credit Losses For Unfunded Commitments ReserveCreditLossesForUnfundedCommitments	479000
CY2022Q4	efsi	Reserve Credit Losses For Unfunded Commitments ReserveCreditLossesForUnfundedCommitments	65000
CY2023	efsi	Initial Adjustment For The Adoption Of Credit Losses For Unfunded Commitments InitialAdjustmentForTheAdoptionOfCreditLossesForUnfundedCommitments	406000
CY2023	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	8000
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	250000
CY2023Q4	efsi	Percentage To Represent More Likely Than Not PercentageToRepresentMoreLikelyThanNot	0.50
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-size:10pt;margin-top:14pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Reclassifications</span></p><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain reclassifications have been made to the 2022 financial statements to conform to reporting for 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The results of the reclassifications are not considered material and had no effect on prior years' net income or shareholders' equity.</span></p>
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3523547
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3482368
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3523547
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3482368
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0
CY2023Q2	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	150000
CY2023	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	8531
CY2023	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	35.34
CY2022	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	4442
CY2022	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	34.79
CY2023Q4	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	145059
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Effect Of Change In Method FinancingReceivableAllowanceForCreditLossesEffectOfChangeInMethod	2500000
CY2023Q4	us-gaap	Translation Adjustment For Net Investment Hedge Net Of Tax TranslationAdjustmentForNetInvestmentHedgeNetOfTax	2000000
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	160251000
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1000
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	22809000
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	137443000
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	175059000
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2000
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	25905000
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	149156000
CY2023Q4	us-gaap	Restricted Investments RestrictedInvestments	9568000
CY2022Q4	us-gaap	Restricted Investments RestrictedInvestments	9233000
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	1268000
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	1256000
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	6114000
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	5799000
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	19434000
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	17568000
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	133435000
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	112820000
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	160251000
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	137443000
CY2022	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	6000
CY2022	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	743000
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	221000
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	29000
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	136221000
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	22780000
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	136442000
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	22809000
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	46407000
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	5336000
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	101456000
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	20569000
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	147863000
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	25905000
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2023Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	1455159000
CY2022Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	1316340000
CY2023Q4	us-gaap	Loans And Leases Receivable Deferred Income LoansAndLeasesReceivableDeferredIncome	-7527000
CY2022Q4	us-gaap	Loans And Leases Receivable Deferred Income LoansAndLeasesReceivableDeferredIncome	-7443000
CY2023Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	14493000
CY2022Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	11218000
CY2023Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1448193000
CY2022Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1312565000
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	11218000
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	8787000
CY2023	efsi	Cumulative Effect Adjustment CumulativeEffectAdjustment	2077000
CY2022	efsi	Cumulative Effect Adjustment CumulativeEffectAdjustment	0
CY2023	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	1641000
CY2022	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	1830000
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	298000
CY2022	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	1260000
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	741000
CY2022	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	659000
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	14493000
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	11218000
CY2023Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1452899000
CY2023Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	1455159000
CY2023Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	181000
CY2023Q4	us-gaap	Financing Receivable Nonaccrual No Allowance FinancingReceivableNonaccrualNoAllowance	5645000
CY2023Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	5645000
CY2022Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	1316340000
CY2022Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	318000
CY2022Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	2162000
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	11218000
CY2023	efsi	Cumulative Effect Adjustment CumulativeEffectAdjustment	2077000
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	741000
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	298000
CY2023	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	1641000
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	14493000
CY2023Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	0
CY2023Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	14493000
CY2023Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	1455159000
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	5574000
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	1449585000
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	8787000
CY2022	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	659000
CY2022	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	1260000
CY2022	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	1830000
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	11218000
CY2022Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	100000
CY2022Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	11118000
CY2022Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	1316340000
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	6621000
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	1309719000
CY2023Q4	efsi	Commercial And Industrial Loans CommercialAndIndustrialLoans	5574000
CY2022Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1199230000
CY2023	efsi	Mortgage Loans On Real Estate Weighted Average Term MortgageLoansOnRealEstateWeightedAverageTerm	P1Y
CY2022	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	28
CY2022Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	4600000
CY2022Q4	efsi	Financing Receivable Modifications Nonaccrual Numberof Contracts FinancingReceivableModificationsNonaccrualNumberofContracts	2
CY2022Q4	efsi	Financing Receivable Modifications Nonaccrual Recorded Investment FinancingReceivableModificationsNonaccrualRecordedInvestment	133000
CY2022	efsi	Troubled Debt Restructuring Modifications Number Of Contracts TroubledDebtRestructuringModificationsNumberOfContracts	13
CY2022	efsi	Troubled Debt Restructuring Modifications Pre Modification Recorded Investment TroubledDebtRestructuringModificationsPreModificationRecordedInvestment	2681000
CY2022	efsi	Troubled Debt Restructuring Modifications Post Modification Recorded Investment TroubledDebtRestructuringModificationsPostModificationRecordedInvestment	2710000
CY2022	efsi	Troubled Debt Restructuring Modifications By Granting Concession Number Of Contracts TroubledDebtRestructuringModificationsByGrantingConcessionNumberOfContracts	13
CY2022	efsi	Troubled Debt Restructuring Modifications By Granting A Refinance TroubledDebtRestructuringModificationsByGrantingARefinance	1
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	35620000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	34638000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	17512000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16574000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	18108000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	18064000
CY2023Q4	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	436619000
CY2022Q4	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	478750000
CY2023Q4	us-gaap	Interest Bearing Domestic Deposit Negotiable Order Of Withdrawal Now InterestBearingDomesticDepositNegotiableOrderOfWithdrawalNOW	253353000
CY2022Q4	us-gaap	Interest Bearing Domestic Deposit Negotiable Order Of Withdrawal Now InterestBearingDomesticDepositNegotiableOrderOfWithdrawalNOW	189144000
CY2023Q4	us-gaap	Interest Bearing Domestic Deposit Money Market InterestBearingDomesticDepositMoneyMarket	263633000
CY2022Q4	us-gaap	Interest Bearing Domestic Deposit Money Market InterestBearingDomesticDepositMoneyMarket	265290000
CY2023Q4	us-gaap	Interest Bearing Domestic Deposit Savings InterestBearingDomesticDepositSavings	139453000
CY2022Q4	us-gaap	Interest Bearing Domestic Deposit Savings InterestBearingDomesticDepositSavings	172997000
CY2023Q4	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	656439000
CY2022Q4	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	627431000
CY2023Q4	efsi	Time Deposits Lessthan250000 TimeDepositsLessthan250000	257418000
CY2022Q4	efsi	Time Deposits Lessthan250000 TimeDepositsLessthan250000	87531000
CY2023Q4	efsi	Time Deposits250000or More TimeDeposits250000orMore	155846000
CY2022Q4	efsi	Time Deposits250000or More TimeDeposits250000orMore	70363000
CY2023Q4	us-gaap	Time Deposits TimeDeposits	413264000
CY2022Q4	us-gaap	Time Deposits TimeDeposits	157894000
CY2023Q4	us-gaap	Deposits Domestic DepositsDomestic	1506322000
CY2022Q4	us-gaap	Deposits Domestic DepositsDomestic	1264075000
CY2023Q4	efsi	Reciprocal Money Market Accounts Domestic ReciprocalMoneyMarketAccountsDomestic	115700000
CY2022Q4	efsi	Reciprocal Money Market Accounts Domestic ReciprocalMoneyMarketAccountsDomestic	59500000
CY2023Q4	us-gaap	Interest Bearing Domestic Deposit Brokered InterestBearingDomesticDepositBrokered	30100000
CY2022Q4	us-gaap	Interest Bearing Domestic Deposit Brokered InterestBearingDomesticDepositBrokered	4600000
CY2023Q4	us-gaap	Time Deposit Maturities Year One TimeDepositMaturitiesYearOne	402814000
CY2023Q4	us-gaap	Time Deposit Maturities Year Two TimeDepositMaturitiesYearTwo	5019000
CY2023Q4	us-gaap	Time Deposit Maturities Year Three TimeDepositMaturitiesYearThree	2450000
CY2023Q4	us-gaap	Time Deposit Maturities Year Four TimeDepositMaturitiesYearFour	1844000
CY2023Q4	us-gaap	Time Deposit Maturities Year Five TimeDepositMaturitiesYearFive	327000
CY2023Q4	us-gaap	Time Deposit Maturities After Year Five TimeDepositMaturitiesAfterYearFive	810000
CY2023Q4	us-gaap	Time Deposits TimeDeposits	413264000
CY2023Q4	us-gaap	Deposit Liabilities Reclassified As Loans Receivable1 DepositLiabilitiesReclassifiedAsLoansReceivable1	253000
CY2022Q4	us-gaap	Deposit Liabilities Reclassified As Loans Receivable1 DepositLiabilitiesReclassifiedAsLoansReceivable1	218000
CY2023Q4	efsi	Short Term Borrowings Consisting Of Fhlb Advances And Federal Funds Purchased Balance At Year End ShortTermBorrowingsConsistingOfFhlbAdvancesAndFederalFundsPurchasedBalanceAtYearEnd	20000000
CY2022Q4	efsi	Short Term Borrowings Consisting Of Fhlb Advances And Federal Funds Purchased Balance At Year End ShortTermBorrowingsConsistingOfFhlbAdvancesAndFederalFundsPurchasedBalanceAtYearEnd	207980000
CY2023	efsi	Short Term Borrowings Consisting Of Fhlb Advances And Federal Funds Purchased Average Balance During The Year ShortTermBorrowingsConsistingOfFhlbAdvancesAndFederalFundsPurchasedAverageBalanceDuringTheYear	45801000
CY2022	efsi	Short Term Borrowings Consisting Of Fhlb Advances And Federal Funds Purchased Average Balance During The Year ShortTermBorrowingsConsistingOfFhlbAdvancesAndFederalFundsPurchasedAverageBalanceDuringTheYear	47470000
CY2023	efsi	Short Term Borrowings Consisting Of Fhlb Advances And Federal Funds Purchased Average Interest Rate During The Year ShortTermBorrowingsConsistingOfFhlbAdvancesAndFederalFundsPurchasedAverageInterestRateDuringTheYear	0.0468
CY2022	efsi	Short Term Borrowings Consisting Of Fhlb Advances And Federal Funds Purchased Average Interest Rate During The Year ShortTermBorrowingsConsistingOfFhlbAdvancesAndFederalFundsPurchasedAverageInterestRateDuringTheYear	0.0309
CY2023	efsi	Short Term Borrowings Federal Funds Purchased Maximum Month End Balance During The Year ShortTermBorrowingsFederalFundsPurchasedMaximumMonthEndBalanceDuringTheYear	150000000
CY2022	efsi	Short Term Borrowings Federal Funds Purchased Maximum Month End Balance During The Year ShortTermBorrowingsFederalFundsPurchasedMaximumMonthEndBalanceDuringTheYear	207980000
CY2023Q4	efsi	Federal Home Loan Bank Irrevocable Letterof Credit FederalHomeLoanBankIrrevocableLetterofCredit	115600000
CY2023Q4	us-gaap	Federal Home Loan Bank Advances General Debt Obligations Disclosures Amount Of Available Unused Funds FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresAmountOfAvailableUnusedFunds	169600000
CY2023Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.045
CY2023	efsi	Fixed Rate End Date FixedRateEndDate	2027-04-01
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	673000
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	30000000
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	30000000
CY2023Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	556000
CY2022Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	623000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses	3043000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses	2342000
CY2023Q4	efsi	Reserve For Unfunded Commitments ReserveForUnfundedCommitments	101000
CY2022Q4	efsi	Reserve For Unfunded Commitments ReserveForUnfundedCommitments	14000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	327000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	222000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits	18000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits	21000
CY2023Q4	efsi	Deferred Tax Assets Home Equity Origination Costs DeferredTaxAssetsHomeEquityOriginationCosts	85000
CY2022Q4	efsi	Deferred Tax Assets Home Equity Origination Costs DeferredTaxAssetsHomeEquityOriginationCosts	81000
CY2023Q4	efsi	Accrued Incentive Benefit AccruedIncentiveBenefit	89000
CY2022Q4	efsi	Accrued Incentive Benefit AccruedIncentiveBenefit	0
CY2023Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	75000
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	48000
CY2023Q4	efsi	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	977000
CY2022Q4	efsi	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	1045000
CY2023Q4	efsi	Credit Carryforward CreditCarryforward	1689000
CY2022Q4	efsi	Credit Carryforward CreditCarryforward	648000
CY2023Q4	us-gaap	Deferred Tax Assets Other Comprehensive Loss DeferredTaxAssetsOtherComprehensiveLoss	4790000
CY2022Q4	us-gaap	Deferred Tax Assets Other Comprehensive Loss DeferredTaxAssetsOtherComprehensiveLoss	5440000
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	25000
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	26000
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	11219000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	9887000
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	853000
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	710000
CY2023Q4	efsi	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	921000
CY2022Q4	efsi	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	1001000
CY2023Q4	efsi	Loan Servicing Rights LoanServicingRights	32000
CY2022Q4	efsi	Loan Servicing Rights LoanServicingRights	144000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1806000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1855000
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	9413000
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	8032000
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2785000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3236000
CY2023	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-1509000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	23079
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	32.11
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	35.19
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	17402
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	33.26
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	2405
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	35.4
CY2022	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-86000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1276000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3150000
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	2232000
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	3711000
CY2023	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	76000
CY2022	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	81000
CY2023	efsi	Effective Income Tax Rate Reconciliation Tax Exempt Income Life Insurance Amount EffectiveIncomeTaxRateReconciliationTaxExemptIncomeLifeInsuranceAmount	134000
CY2022	efsi	Effective Income Tax Rate Reconciliation Tax Exempt Income Life Insurance Amount EffectiveIncomeTaxRateReconciliationTaxExemptIncomeLifeInsuranceAmount	131000
CY2023	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	756000
CY2022	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	353000
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	10000
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	4000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1276000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3150000
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.12
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.1783
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	250000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	38780
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	33.47
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	31738
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	30.7
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	37941
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	35.79
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	31648
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	1527
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	32.13
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	56914
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	35.06
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	38780
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	33.47
CY2023	us-gaap	Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense	1200000
CY2022	us-gaap	Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense	1000000
CY2023	efsi	Deferred Compensation Arrangement Grant Date Fair Value Of Vested Restricted Stock DeferredCompensationArrangementGrantDateFairValueOfVestedRestrictedStock	579000
CY2022	efsi	Deferred Compensation Arrangement Grant Date Fair Value Of Vested Restricted Stock DeferredCompensationArrangementGrantDateFairValueOfVestedRestrictedStock	741000
CY2023	efsi	Deferred Compensation Arrangement Vest Date Fair Value Of Vested Restricted Stock DeferredCompensationArrangementVestDateFairValueOfVestedRestrictedStock	609000
CY2022	efsi	Deferred Compensation Arrangement Vest Date Fair Value Of Vested Restricted Stock DeferredCompensationArrangementVestDateFairValueOfVestedRestrictedStock	819000
CY2023	efsi	Deferred Compensation Arrangements Unrecognized Compensation Cost Related To Unvested Restricted Stock DeferredCompensationArrangementsUnrecognizedCompensationCostRelatedToUnvestedRestrictedStock	456000
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y
CY2023	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.50
CY2023	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.06
CY2023Q4	efsi	Non Elective Safe Harbor Employer Contribution And Age Weighted Employer Contribution Percent NonElectiveSafeHarborEmployerContributionAndAgeWeightedEmployerContributionPercent	0.03
CY2023	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	2200000
CY2022	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	1900000
CY2023	efsi	Maximum Age Benefits Can Be Reduced Or Forfeited Due To Employment Termination MaximumAgeBenefitsCanBeReducedOrForfeitedDueToEmploymentTermination	P65Y
CY2023Q4	efsi	Executive Supplemental Income Benefit Liability ExecutiveSupplementalIncomeBenefitLiability	4000
CY2022Q4	efsi	Executive Supplemental Income Benefit Liability ExecutiveSupplementalIncomeBenefitLiability	8000
CY2023	efsi	Executive Supplemental Income Benefit Expense ExecutiveSupplementalIncomeBenefitExpense	29000
CY2022	efsi	Executive Supplemental Income Benefit Expense ExecutiveSupplementalIncomeBenefitExpense	29000
CY2023Q4	us-gaap	Compensating Balance Amount CompensatingBalanceAmount	250000
CY2022Q4	us-gaap	Compensating Balance Amount CompensatingBalanceAmount	250000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4653000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4978000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4387000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4766000
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P14Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P14Y
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0309
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0304
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	528000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	528000
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	0
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	0
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	14000
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	15000
CY2023	us-gaap	Lease Cost LeaseCost	542000
CY2022	us-gaap	Lease Cost LeaseCost	543000
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	473000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	466000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	480000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	504000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	397000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	391000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	395000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	3754000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	5921000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1268000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4653000
CY2023Q4	us-gaap	Banking Regulation Tier One Leverage Capital Ratio Undercapitalized Minimum BankingRegulationTierOneLeverageCapitalRatioUndercapitalizedMinimum	0.09
CY2022	us-gaap	Banking Regulation Maximum Leverage Payout Ratio BankingRegulationMaximumLeveragePayoutRatio	0.08
CY2022Q4	us-gaap	Banking Regulation Tier One Leverage Capital Ratio Undercapitalized Minimum BankingRegulationTierOneLeverageCapitalRatioUndercapitalizedMinimum	0.09
CY2023	us-gaap	Banking Regulation Maximum Leverage Payout Ratio BankingRegulationMaximumLeveragePayoutRatio	0.0848
CY2023Q4	us-gaap	Common Equity Tier One Capital CommonEquityTierOneCapital	155453000
CY2023Q4	efsi	Common Equity Tier One Capitalto Risk Weighted Assets CommonEquityTierOneCapitaltoRiskWeightedAssets	0.1027
CY2023Q4	us-gaap	Common Equity Tier One Capital Required For Capital Adequacy CommonEquityTierOneCapitalRequiredForCapitalAdequacy	68121000
CY2023Q4	efsi	Common Equity Tier One Capital For Capital Adequacy To Risk Weighted Assets CommonEquityTierOneCapitalForCapitalAdequacyToRiskWeightedAssets	0.045
CY2023Q4	us-gaap	Common Equity Tier One Capital Required To Be Well Capitalized CommonEquityTierOneCapitalRequiredToBeWellCapitalized	98397000
CY2023Q4	efsi	Common Equity Tier One Capital Required To Be Well Capitalized To Risk Weighted Assets CommonEquityTierOneCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.065
CY2023Q4	us-gaap	Capital Capital	168925000
CY2023Q4	efsi	Capital To Risk Weighted Assets1 CapitalToRiskWeightedAssets1	0.1116
CY2023Q4	us-gaap	Capital Required For Capital Adequacy CapitalRequiredForCapitalAdequacy	121104000
CY2023Q4	efsi	Capital Required For Capital Adequacy To Risk Weighted Assets1 CapitalRequiredForCapitalAdequacyToRiskWeightedAssets1	0.08
CY2023Q4	us-gaap	Capital Required To Be Well Capitalized CapitalRequiredToBeWellCapitalized	151380000
CY2023Q4	efsi	Capital Required To Be Well Capitalized To Risk Weighted Assets1 CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets1	0.10
CY2023Q4	us-gaap	Tier One Risk Based Capital TierOneRiskBasedCapital	155453000
CY2023Q4	efsi	Tier One Risk Based Capital To Risk Weighted Assets1 TierOneRiskBasedCapitalToRiskWeightedAssets1	0.1027
CY2023Q4	us-gaap	Tier One Risk Based Capital Required For Capital Adequacy TierOneRiskBasedCapitalRequiredForCapitalAdequacy	90828000
CY2023Q4	efsi	Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets1 TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets1	0.06
CY2023Q4	us-gaap	Tier One Risk Based Capital Required To Be Well Capitalized TierOneRiskBasedCapitalRequiredToBeWellCapitalized	121104000
CY2023Q4	efsi	Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets1 TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets1	0.08
CY2023Q4	us-gaap	Tier One Leverage Capital TierOneLeverageCapital	155453000
CY2023Q4	efsi	Tier One Leverage Capital To Average Assets1 TierOneLeverageCapitalToAverageAssets1	0.0848
CY2023Q4	us-gaap	Tier One Leverage Capital Required For Capital Adequacy TierOneLeverageCapitalRequiredForCapitalAdequacy	73367000
CY2023Q4	efsi	Tier One Leverage Capital Required For Capital Adequacy To Average Assets1 TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets1	0.04
CY2023Q4	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized TierOneLeverageCapitalRequiredToBeWellCapitalized	91709000
CY2023Q4	efsi	Tier One Leverage Capital Required To Be Well Capitalized To Average Assets1 TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets1	0.05
CY2022Q4	us-gaap	Tier One Leverage Capital TierOneLeverageCapital	142530000
CY2022Q4	efsi	Tier One Leverage Capital To Average Assets1 TierOneLeverageCapitalToAverageAssets1	0.0915
CY2022Q4	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized TierOneLeverageCapitalRequiredToBeWellCapitalized	140210000
CY2022Q4	efsi	Tier One Leverage Capital Required To Be Well Capitalized To Average Assets1 TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets1	0.09
CY2023Q4	efsi	Capital Conservation Bufferd Rate CapitalConservationBufferdRate	0.025
CY2023Q4	us-gaap	Statutory Accounting Practices Statutory Amount Available For Dividend Payments StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPayments	32300000
CY2023Q4	efsi	Restricted Equity In Net Assets Of Bank RestrictedEquityInNetAssetsOfBank	103900000
CY2023	efsi	Funds Available For Loans Or Advances FundsAvailableForLoansOrAdvances	16900000
CY2023	efsi	Initial Adjustment For The Adoption Of Credit Losses For Unfunded Commitments InitialAdjustmentForTheAdoptionOfCreditLossesForUnfundedCommitments	406000
CY2023Q4	efsi	Reserve Credit Losses For Unfunded Commitments ReserveCreditLossesForUnfundedCommitments	479000
CY2023Q4	us-gaap	Noninterest Income NoninterestIncome	3653000
CY2023	efsi	Financial Instruments Commitments To Extend Credit FinancialInstrumentsCommitmentsToExtendCredit	37724000
CY2022	efsi	Financial Instruments Commitments To Extend Credit FinancialInstrumentsCommitmentsToExtendCredit	27927000
CY2023	efsi	Financial Instruments Unfunded Commitments Under Lines Of Credit FinancialInstrumentsUnfundedCommitmentsUnderLinesOfCredit	227717000
CY2022	efsi	Financial Instruments Unfunded Commitments Under Lines Of Credit FinancialInstrumentsUnfundedCommitmentsUnderLinesOfCredit	191259000
CY2023	efsi	Financial Instruments Commercial And Standby Letters Of Credit FinancialInstrumentsCommercialAndStandbyLettersOfCredit	3964000
CY2022	efsi	Financial Instruments Commercial And Standby Letters Of Credit FinancialInstrumentsCommercialAndStandbyLettersOfCredit	7069000
CY2023Q4	efsi	Collateralized Letters Of Credit Outstanding CollateralizedLettersOfCreditOutstanding	3800000
CY2023	efsi	Excess Of Insurance Limits Held In Cash Accounts In Other Commercial Banks ExcessOfInsuranceLimitsHeldInCashAccountsInOtherCommercialBanks	9000000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3000
CY2023	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	14000
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-11000
CY2023	us-gaap	Gain Loss On Disposition Of Other Financial Assets GainLossOnDispositionOfOtherFinancialAssets	435000
CY2022	us-gaap	Gain Loss On Disposition Of Other Financial Assets GainLossOnDispositionOfOtherFinancialAssets	0
CY2023	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	0
CY2022	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	-737000
CY2023	efsi	Gain On Sale Of Loans Held For Sale GainOnSaleOfLoansHeldForSale	1428000
CY2022	efsi	Gain On Sale Of Loans Held For Sale GainOnSaleOfLoansHeldForSale	1875000
CY2023	efsi	Bank Owned Life Insurance Income Expense BankOwnedLifeInsuranceIncomeExpense	713000
CY2022	efsi	Bank Owned Life Insurance Income Expense BankOwnedLifeInsuranceIncomeExpense	626000
CY2023	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	1006000
CY2022	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	1882000
CY2023	us-gaap	Noninterest Income NoninterestIncome	14745000
CY2022	us-gaap	Noninterest Income NoninterestIncome	13345000
CY2023Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	18558000
CY2023Q2	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	20364000
CY2023Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	22191000
CY2023Q4	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	22015000
CY2023Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	11980000
CY2023Q2	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	12039000
CY2023Q3	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	12700000
CY2023Q4	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	11923000
CY2023Q1	us-gaap	Noninterest Income NoninterestIncome	3526000
CY2023Q2	us-gaap	Noninterest Income NoninterestIncome	3357000
CY2023Q3	us-gaap	Noninterest Income NoninterestIncome	4209000
CY2023Q1	us-gaap	Noninterest Expense NoninterestExpense	12386000
CY2023Q2	us-gaap	Noninterest Expense NoninterestExpense	12955000
CY2023Q3	us-gaap	Noninterest Expense NoninterestExpense	14133000
CY2023Q4	us-gaap	Noninterest Expense NoninterestExpense	13280000
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3120000
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2441000
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2776000
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2296000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	2585000
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	2058000
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	2319000
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	2395000
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.73
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.58
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.66
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.69
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.73
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.58
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.66
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.69
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.3
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.3
CY2023Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.3
CY2023Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.3
CY2022Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	11509000
CY2022Q2	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	12647000
CY2022Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	14366000
CY2022Q4	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	16164000
CY2022Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	10599000
CY2022Q2	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	11559000
CY2022Q3	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	12899000
CY2022Q4	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	12326000
CY2022Q1	us-gaap	Noninterest Income NoninterestIncome	3243000
CY2022Q2	us-gaap	Noninterest Income NoninterestIncome	3849000
CY2022Q3	us-gaap	Noninterest Income NoninterestIncome	3164000
CY2022Q4	us-gaap	Noninterest Income NoninterestIncome	3089000
CY2022Q1	us-gaap	Noninterest Expense NoninterestExpense	9923000
CY2022Q2	us-gaap	Noninterest Expense NoninterestExpense	10528000
CY2022Q3	us-gaap	Noninterest Expense NoninterestExpense	11058000
CY2022Q4	us-gaap	Noninterest Expense NoninterestExpense	11548000
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3919000
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4880000
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5005000
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3867000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	3250000
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	3992000
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	4082000
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	3197000
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.94
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.14
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.17
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.92
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.94
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.14
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.17
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.92
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.28
CY2022Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.28
CY2022Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.29
CY2022Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.3
CY2023Q4	us-gaap	Interest Rate Derivative Liabilities At Fair Value InterestRateDerivativeLiabilitiesAtFairValue	1465000
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	138908000
CY2023Q4	us-gaap	Interest Rate Derivative Assets At Fair Value InterestRateDerivativeAssetsAtFairValue	1465000
CY2023Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	1465000
CY2022Q4	us-gaap	Interest Rate Derivative Assets At Fair Value InterestRateDerivativeAssetsAtFairValue	1017000
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	150173000
CY2022Q4	us-gaap	Interest Rate Derivative Liabilities At Fair Value InterestRateDerivativeLiabilitiesAtFairValue	1017000
CY2022Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	1017000
CY2023Q4	efsi	Balance Other Real Estate Owned BalanceOtherRealEstateOwned	0
CY2022Q4	efsi	Balance Other Real Estate Owned BalanceOtherRealEstateOwned	108000
CY2023Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	138353000
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	137443000
CY2023Q4	us-gaap	Restricted Investments At Fair Value RestrictedInvestmentsAtFairValue	9568000
CY2023Q4	us-gaap	Loans Held For Sale Fair Value Disclosure LoansHeldForSaleFairValueDisclosure	1661000
CY2023Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	1448193000
CY2023Q4	us-gaap	Cash Surrender Value Fair Value Disclosure CashSurrenderValueFairValueDisclosure	29575000
CY2023Q4	efsi	Accrued Interest Receivable Fair Value Disclosure AccruedInterestReceivableFairValueDisclosure	5008000
CY2023Q4	us-gaap	Interest Rate Derivative Assets At Fair Value InterestRateDerivativeAssetsAtFairValue	1465000
CY2023Q4	us-gaap	Deposits Fair Value Disclosure DepositsFairValueDisclosure	1506322000
CY2023Q4	us-gaap	Fair Value Liabilities Measured On Recurring Basis Subordinated Debt Obligations FairValueLiabilitiesMeasuredOnRecurringBasisSubordinatedDebtObligations	29444000
CY2023Q4	us-gaap	Accrued Liabilities Fair Value Disclosure AccruedLiabilitiesFairValueDisclosure	2364000
CY2023Q4	us-gaap	Interest Rate Derivative Liabilities At Fair Value InterestRateDerivativeLiabilitiesAtFairValue	1465000
CY2022Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	66894000
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	149156000
CY2022Q4	us-gaap	Restricted Investments At Fair Value RestrictedInvestmentsAtFairValue	9233000
CY2022Q4	us-gaap	Loans Held For Sale Fair Value Disclosure LoansHeldForSaleFairValueDisclosure	153000
CY2022Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	1312565000
CY2022Q4	us-gaap	Cash Surrender Value Fair Value Disclosure CashSurrenderValueFairValueDisclosure	23862000
CY2022Q4	efsi	Accrued Interest Receivable Fair Value Disclosure AccruedInterestReceivableFairValueDisclosure	3902000
CY2022Q4	us-gaap	Interest Rate Derivative Assets At Fair Value InterestRateDerivativeAssetsAtFairValue	1017000
CY2022Q4	us-gaap	Deposits Fair Value Disclosure DepositsFairValueDisclosure	1264075000
CY2022Q4	us-gaap	Federal Funds Purchased FederalFundsPurchased	32980000
CY2022Q4	us-gaap	Federal Home Loan Bank Advances FederalHomeLoanBankAdvances	175000000
CY2022Q4	us-gaap	Fair Value Liabilities Measured On Recurring Basis Subordinated Debt Obligations FairValueLiabilitiesMeasuredOnRecurringBasisSubordinatedDebtObligations	29377000
CY2022Q4	us-gaap	Accrued Liabilities Fair Value Disclosure AccruedLiabilitiesFairValueDisclosure	926000
CY2022Q4	us-gaap	Interest Rate Derivative Liabilities At Fair Value InterestRateDerivativeLiabilitiesAtFairValue	1017000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-20446000
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-155000
CY2023	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	3087000
CY2022	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	-26422000
CY2022	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	737000
CY2023	efsi	Other Comprehensive Income Loss Tax Effect Of Current Period Changes OtherComprehensiveIncomeLossTaxEffectOfCurrentPeriodChanges	-647000
CY2022	efsi	Other Comprehensive Income Loss Tax Effect Of Current Period Changes OtherComprehensiveIncomeLossTaxEffectOfCurrentPeriodChanges	5394000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2440000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-20291000
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-18006000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-20446000
CY2023	dei	Auditor Firm AuditorFirmId	613
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2022Q4	us-gaap	Other Real Estate OtherRealEstate	108000
CY2023	us-gaap	Other Real Estate Additions OtherRealEstateAdditions	0
CY2022	us-gaap	Other Real Estate Additions OtherRealEstateAdditions	108000
CY2023	us-gaap	Other Real Estate Disposals OtherRealEstateDisposals	108000
CY2023	us-gaap	Other Real Estate Valuation Adjustments OtherRealEstateValuationAdjustments	0
CY2022Q4	us-gaap	Other Real Estate OtherRealEstate	108000
CY2022Q4	efsi	Other Real Estate Gross OtherRealEstateGross	108000
CY2022Q4	us-gaap	Other Real Estate OtherRealEstate	108000
CY2023Q4	us-gaap	Amortization Method Qualified Affordable Housing Project Investments AmortizationMethodQualifiedAffordableHousingProjectInvestments	2000000
CY2022Q4	us-gaap	Amortization Method Qualified Affordable Housing Project Investments AmortizationMethodQualifiedAffordableHousingProjectInvestments	2300000
CY2023Q4	us-gaap	Qualified Affordable Housing Project Investments Commitment QualifiedAffordableHousingProjectInvestmentsCommitment	0
CY2022Q4	us-gaap	Qualified Affordable Housing Project Investments Commitment QualifiedAffordableHousingProjectInvestmentsCommitment	0
CY2023	us-gaap	Amortization Method Qualified Affordable Housing Project Investments Amortization AmortizationMethodQualifiedAffordableHousingProjectInvestmentsAmortization	265000
CY2022	us-gaap	Amortization Method Qualified Affordable Housing Project Investments Amortization AmortizationMethodQualifiedAffordableHousingProjectInvestmentsAmortization	278000
CY2023	efsi	Affordable Housing Tax Creditsand Other Tax Benefits Expectedto Be Received AffordableHousingTaxCreditsandOtherTaxBenefitsExpectedtoBeReceived	354000
CY2023	us-gaap	Affordable Housing Tax Credits And Other Tax Benefits Amount AffordableHousingTaxCreditsAndOtherTaxBenefitsAmount	389000
CY2022	us-gaap	Affordable Housing Tax Credits And Other Tax Benefits Amount AffordableHousingTaxCreditsAndOtherTaxBenefitsAmount	387000

Files In Submission

Name	View Source	Status
0000950170-24-038718-index-headers.html	Edgar Link	pending
0000950170-24-038718-index.html	Edgar Link	pending
0000950170-24-038718.txt	Edgar Link	pending
0000950170-24-038718-xbrl.zip	Edgar Link	pending
efsi-20231231.htm	Edgar Link	pending
efsi-20231231.xsd	Edgar Link	pending
efsi-ex21_1.htm	Edgar Link	pending
efsi-ex23_1.htm	Edgar Link	pending
efsi-ex31_1.htm	Edgar Link	pending
efsi-ex31_2.htm	Edgar Link	pending
efsi-ex32_1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img213553172_0.jpg	Edgar Link	pending
img78055599_0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
efsi-20231231_htm.xml	Edgar Link	completed
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EFSI
EAGLE FINANCIAL SERVICES INC Stock $efsi

2024 Q1 Form 10-K Financial Statement

#000095017024038718 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EFSI EAGLE FINANCIAL SERVICES INC Stock $efsi

2024 Q1 Form 10-K Financial Statement

#000095017024038718 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EFSI
EAGLE FINANCIAL SERVICES INC Stock $efsi